{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:00:48Z","timestamp":1793134848699,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503310"],"award-info":[{"award-number":["81503310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603159"],"award-info":[{"award-number":["81603159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["201415"],"award-info":[{"award-number":["201415"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015M582679"],"award-info":[{"award-number":["2015M582679"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018621","name":"Program for Changjiang Scholars and Innovative Research Team in University","doi-asserted-by":"publisher","award":["ITR1171"],"award-info":[{"award-number":["ITR1171"]}],"id":[{"id":"10.13039\/501100018621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.biopha.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:26:29Z","timestamp":1515111989000},"page":"806-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity"],"prefix":"10.1016","volume":"98","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"30","key":"10.1016\/j.biopha.2018.01.002_bib0005","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.3748\/wjg.v22.i30.6800","article-title":"Hepatitis-related hepatocellular carcinoma: insights into cytokine gene polymorphisms","volume":"22","author":"Dondeti","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.biopha.2018.01.002_bib0010","doi-asserted-by":"crossref","first-page":"20434","DOI":"10.3390\/ijms151120434","article-title":"Inhibition of the Wnt\/\u03b2-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma, long non-coding RNAs: critical players in hepatocellular carcinoma","volume":"15","author":"Sun","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.002_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2016.07.013","article-title":"Inhibition of the Wnt\/beta-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma","volume":"381","author":"Lin","year":"2016","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.002_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11596-007-0217-8","article-title":"The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance","volume":"27","author":"Li","year":"2007","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.002_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.115.101360","article-title":"A Gene expression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strategy","volume":"89","author":"Gillet","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2018.01.002_bib0030","doi-asserted-by":"crossref","first-page":"29760","DOI":"10.18632\/oncotarget.15964","article-title":"Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells","volume":"8","author":"Wen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2005.06.005","article-title":"Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity","volume":"30","author":"Biscardi","year":"2006","journal-title":"Leuk Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.01.002_bib0040","doi-asserted-by":"crossref","first-page":"e72927","DOI":"10.1371\/journal.pone.0072927","article-title":"Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.01.002_bib0045","first-page":"268963","article-title":"Traditional herbal medicine: a review of potential of inhibitory hepatocellular carcinoma in basic research and clinical trial","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.002_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/or.2014.3550","article-title":"Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN\/Akt\/HIF-1alpha signaling pathway","volume":"33","author":"Chen","year":"2015","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.002_bib0055","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1159\/000470815","article-title":"Baicalein, a natural anti-cancer compound, alters MicroRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells","volume":"41","author":"Bie","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.002_bib0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3892\/ijo.2012.1510","article-title":"Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling","volume":"41","author":"Liang","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.01.002_bib0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2016.09.001","article-title":"Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition","volume":"513","author":"Meng","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2018.01.002_bib0070","doi-asserted-by":"crossref","first-page":"31009","DOI":"10.1038\/srep31009","article-title":"Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.002_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2008.04.033","article-title":"Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402\/5-FU","volume":"269","author":"Shi","year":"2008","journal-title":"Cancer Lett."},{"issue":"36","key":"10.1016\/j.biopha.2018.01.002_bib0080","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.3748\/wjg.15.4538","article-title":"Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract","volume":"15","author":"Li","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"20","key":"10.1016\/j.biopha.2018.01.002_bib0085","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s00018-008-8111-5","article-title":"An overview of cancer multidrug resistance: a still unsolved problem","volume":"65","author":"Lage","year":"2008","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.002_bib0090","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3892\/or.2017.5410","article-title":"Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin","volume":"37","author":"Yuan","year":"2017","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.002_bib0095","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/ijc.29574","article-title":"Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis","volume":"137","author":"Yang","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2018.01.002_bib0100","doi-asserted-by":"crossref","first-page":"e71071","DOI":"10.1371\/journal.pone.0071071","article-title":"Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-kappaB and MAPK\/ERK mediated YB-1 activity in A2780\/T cells","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.biopha.2018.01.002_bib0105","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1007\/s00216-016-9847-7","article-title":"A targeted proteomics approach to the quantitative analysis of ERK\/Bcl-2-mediated anti-apoptosis and multi-drug resistance in breast cancer","volume":"408","author":"Yang","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.002_bib0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/156800909788166600","article-title":"Overcoming drug resistance by enhancing apoptosis of tumor cells","volume":"9","author":"Gimenez-Bonafe","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.002_bib0115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000485285","article-title":"Multiple roles of autophagy in the Sorafenib resistance of hepatocellular carcinoma","volume":"44","author":"Sun","year":"2017","journal-title":"Cell Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.002_bib0120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1159\/000485286","article-title":"Ablation of ATG4B suppressed autophagy and activated AMPK for cell cycle arrest in cancer cells","volume":"44","author":"Liu","year":"2017","journal-title":"Cell Physiol. Biochem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217335382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217335382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:32:30Z","timestamp":1760095950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217335382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"alternative-id":["S0753332217335382"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.002","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}